Leap Therapeutics, Inc. (LPTX)
NASDAQ: LPTX · Real-Time Price · USD
0.3051
-0.0115 (-3.63%)
At close: Mar 31, 2025, 4:00 PM
0.3079
+0.0028 (0.91%)
After-hours: Mar 31, 2025, 5:35 PM EDT
Leap Therapeutics Employees
Leap Therapeutics had 54 employees as of December 31, 2023. The number of employees increased by 10 or 22.73% compared to the previous year.
Employees
54
Change (1Y)
10
Growth (1Y)
22.73%
Revenue / Employee
n/a
Profits / Employee
-$1,259,685
Market Cap
12.59M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
LPTX News
- 4 hours ago - Leap Therapeutics (LPTX) Conference Call to discuss Updated Data from Part B of the DeFianCe Study Transcript - Seeking Alpha
- 5 days ago - Penny Stock Leap Therapeutics Unveils Positive Data From Experimental Combo Therapy For Colorectal Cancer - Benzinga
- 5 days ago - Leap Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results - PRNewsWire
- 5 days ago - Leap Therapeutics Reports Positive Updated Data from Sirexatamab Colorectal Cancer Study - PRNewsWire
- 2 months ago - Leap Therapeutics Reports Initial Clinical Data from Part B of the DeFianCe Study and Part C of the DisTinGuish Study - PRNewsWire
- 3 months ago - Leap Therapeutics: A Buy On Near-Term Data Catalysts In Stomach And Colon Cancer - Seeking Alpha
- 3 months ago - Leap Therapeutics to Participate at the 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 4 months ago - Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare Conference - PRNewsWire